a case study discussion of the new era of applying the...

92
A Case Study Discussion of the New Era of Applying the Functional Medicine Model to Patient Care When Managing Detox-Related Health Concerns Kristi Hughes, ND 2014 South Africa

Upload: vukien

Post on 22-Jul-2018

230 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

A Case Study Discussion of the New Era of Applying the Functional Medicine

Model to Patient Care When Managing Detox-Related Health Concerns

Kristi Hughes, ND 2014 South Africa

Page 2: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Disclosure

• KRISTI HUGHES, ND is the Associate Director for Functional Medicine at the Institute for Functional Medicine.

• She is the Director of Medical Education for Functional Medicine South Africa.

• She is also an Independent Contractor for Metagenics, Nutrition Dynamics, Health World, and Amipro South Africa.

Page 3: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

FUNCTIONAL MEDICINE addresses the underlying causes of disease, using a systems-oriented approach and engaging both patient and practitioner in a therapeutic partnership.

Page 4: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine 4

Page 5: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine 5

Page 6: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine 6

Page 7: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Functional Medicine Operating System

for Identifying Toxicity Concerns

Page 8: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

O T T G

Gather Oneself & Information

Organize on Timeline & Matrix

Tell the Patient’s Story

Order of your Priorities

Initiate Assessment and Care

Track Progress

O I

Page 9: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 10: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

ather

information through intake forms, questionnaires, the initial consultation, physical exam, and objective data. A detailed functional medicine history taken appropriate to age, gender, and nature of presenting problems

Page 11: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Gathering Key Detox Information

Page 12: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Advanced Detox Assessment

Page 13: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

The Functional Medicine

Timeline

Page 14: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 15: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Age Birth

Page 16: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Signs, Symptoms or Diseases Reported

Page 17: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Total Toxic Load (Body Burden)

Over extended periods of time, small daily doses of multiple

contaminants have cumulative detrimental effects on physiologic

pathways that can eventually impair health and cause disease.

Page 18: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Functional Toxicology Triggers

Genomic Predisposition

Mediators

Chronic Disease

Toxins

Page 19: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

ADHD Allergies Alzheimer’s Anemia/ Immune

Suppression

Autism AI Diseases BP and Kidney Disease

Cancer

BPA Lead Mercury Phthalates PCBs

Antimony BPA Cadmium Formaldehyde Mold Nickel Phthalates

Aluminum Lead Mercury

Benzene Cadmium Lead PAHs

Mercury Arsenic Lead Mercury Mold

Arsenic Lead Mercury

Aluminum (breast?) Arsenic Benzene BPA Cadmium EMFs Formaldehyde HAs Lead Nickel Perchloroethylene Phthalates Solvents Vinyl chloride PVC Dioxin

Source: IFM Toolkit

Potential Associations between Toxins & Diseases

Page 20: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

CFS, FA Diabetes/IR Fertility Issues & Menstrual Disorders

Multiple Chemical

Sensitivities

Neuro-behavioral

issues

Neuro-development

issues

Osteoporosis Parkinson’s Peripheral Neuropathy

Arsenic Benzene Cd EMR FA Pb Hg Mold Ni PCE POPs PCBs Solvents PVC Dioxin

Arsenic BPA EMFs Pesticides PCBs PVC Dioxin Vinyl chloride

Arsenic BPA Cd EMF FA Pb Hg Phthalates PCBs PAHs Solvents PVC Dioxin

Benzene FA Mold Pesticides PCBs Solvents Vinyl chloride PVC Dioxin

Al As EMFs Pb Hg Mold Phthalates PCBs Solvents

As Pb Hg PCBs Solvents

Cd Pb

Mn Pesticides

As Pb Hg PCBs

Source: IFM Toolkit

Potential Associations between Toxins & Diseases

Page 21: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

ATMs Antecedents, Triggers, and

Mediators in Case Evaluation

Page 22: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Definitions: Antecedents, Triggers, and Mediators

• Antecedents are factors, genetic or acquired, that predispose individual to an illness or pattern

• Triggers are factors that provoke the symptoms and signs of illness

• Mediators/mediation are factors, biochemical or psychosocial, that contribute to pathological changes and dysfunctional responses

Page 23: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Antecedents

Page 24: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Triggers or Triggering Events

Page 25: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Mediators/Perpetuators

Page 26: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

The ABCDs of Functional Nutrition Evaluation

(Identifying Detox Related Nutrition Concerns)

Dr. Michael Stone

Page 27: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

A B

C D

Anthropometrics Biomarkers & Labs Clinical Indicators Diet and Lifestyle Assessment

The ABCDs of Functional Nutritional

Evaluation

Page 28: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Context Company

Quality

Quantity

ABCD of Nutrition Evaluation

-Anthropometrics -Biochemical Markers -Clinical Findings -Diet Evaluation

Page 29: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Anthropometrics

Page 30: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

NO

NO

Possible High Muscle Mass

or Athlete

NO

Increased BIA Fat%?

YES

Abnormal High BMI?

YES YES YES

NO

Gut/Detox/HPATGG dysfunctions?

Assessing Body Composition

YES

NO YES

Ideal Skinny Fat or Metabolically

Obese

NO

Increased WHR?

TLC Nx/ Rx

YES

Increased BIA Fat%?

NO

Increased WHR?

Increased BIA Fat%?

Metabolically Obese

(OverVAT)

YES NO

Gynoid Obesity/ overSAT

Gynoid Obesity/ overSAT

Possible High Muscle Mass

or Large Skeletal Frame

Increased BIA Fat%?

Android Obesity (OverVAT)

MetSyn?

YES

YES

>25 Overwt >30 Obese

Dx: OverFAT Dx:OverVAT or OverSAT Dx: Overweight

Increased WC?

Increased WC or WHR?

Page 31: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 32: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

Environmental Toxins Affect Obesity

Page 33: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Atrazine, Insulin Resistance and Obesity

“These results suggest that long-term exposure to the herbicide ATZ (atrazine) might contribute to the development of insulin resistance and obesity, particularly where a high-fat diet is prevalent.

ATZ has been extensively used in the USA since the early 1960s, a time frame that corresponds to the beginning of the present obesity epidemic.

ATZ-usage and obesity maps show striking overlaps, suggesting that heavy usage of ATZ may be associated with the risk of obesity.”

Lim S et al. Chronic Exposure to the Herbicide, Atrazine, Causes Mitochondrial Dysfunction and Insulin Resistance. PLoS ONE, April 2009;4(4):e5186.

Page 34: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Abdominal Obesity>Inflammation >Cardiometabolic Syndrome>CVD

Page 35: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Anthropometrics

Biomarkers and Functional Labs (PFC-MVP)

Page 36: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

BioMarkers and Functional Labs

Page 37: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

P F

R

O T

I

E

N

A

T &

C A R

B O H Y

M

I

E

R A

L

N

S

V

I

A

M I

S

T

N

P H

T O

N U

S

Y

T D O I L R

A T E

R I

N T E

S

Page 38: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Putative Serological Biomarkers to Consider for Toxicity

• Gamma-glutamyltransferase (GGT) – >40 units/L

• Uric acid – >8mg/dl

• Homocysteine – >11 micromol/L

• hsC-reactive protein – >0.7 mg/L

• Magnesium – <2meq/dL

• Antinuclear antibody titer – >1:125

• Apo B/Apo A1 – >0.6

• Hemoglobin A1c – >5.5%

• 25-Hydroxyvitamin D3 – <30 ng/ml

• Body Mass Index – >27

• Body Composition – Normal WHR – >30% body fat

• Urinary microalbumin – >30 mg in 24 hr

Page 39: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

GGT: A Novel CV Risk Marker “In the upper reference range, GGT was found to be an independent biomarker of the metabolic syndrome, with a 20% per GGT quartile trend rise. Additionally, GGT was positively correlated with an 18% per quartile risk of cardiovascular events and a 26% per quartile increased risk of all-cause mortality.”

Mason JE et al. Prev Cardiol 2010;13(1):36-41.

Page 40: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Glucose Tolerance Test SI - International Units

75 gm dextrose Optimal Levels • Fasting insulin 28-35 pmol/L • 1/2 hour insulin <215 pmol/L • 1 and 2 hour insulin <215 • Fasting glucose-4.4-5.0mmol/L

• 2 hour glucose- 4.4-6.6mmol/L

• HgA1C < 0.055

Diagnostic IR • >85 pmol/L • > 395 insulin • > 350 insulin • > 5.5 = hypergly • >7.0 = DM2 • > 11 mmol/L - 2

hour glucose • > 0.06 – HgA1C

JAMA 2007;297:2092-102. McAuley, K. Diabetes Care. 2001;24:460-464.

Page 41: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Higher V.A.T. = Higher Glucose and Insulin

Page 42: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Clinical Indicators from Nutrition Physical Exam

Anthropometrics

Biomarkers and Functional Labs (PFC-MVP)

Page 43: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 44: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Diet and Lifestyle Assessment

Clinical Indicators from Nutrition Physical Exam

Anthropometrics

Biomarkers and Functional Labs (PFC-MVP)

Page 45: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Diet, Nutrition, and Lifestyle

Journal

Page 46: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 47: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 48: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

rganize the subjective and objective details from the patient’s story within the functional medicine paradigm Positioning the patient’s presenting signs and symptoms, along with the details of the case history on the timeline and functional medicine matrix

Page 49: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

The Functional Medicine

Matrix

Page 50: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 51: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Biotransformation & Elimination

(e.g., Toxicity, Detoxification)

Page 52: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Defense & Repair (e.g., Immune, Inflammation, Infection/Microbiota)

Assimilation (e.g., Digestion, Absorption, Microbiota/GI, Respiration)

Spiritual

e.g., meaning & purpose, relationship with something greater

e.g., cognitive function, perceptual patterns

e.g., emotional regulation, grief, sadness, anger, etc.

Transport (e.g., Cardiovascular, Lymphatic System)

Biotransformation & Elimination (e.g., Toxicity, Detoxification)

Energy (e.g., Energy Regulation, Mitochondrial Function)

Communication (e.g., Endocrine, Neurotransmitters,

Immune messengers)

Structural Integrity (e.g., from Subcellular Membranes

to Musculoskeletal Structure)

Toxicity Influences

Biotransformation & Elimination

(e.g., Toxicity, Detoxification)

Page 53: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Nutrition Evaluation

Page 54: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Functional Nutrition

Page 55: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Case Based Learning

Page 56: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

O T T G

Gather Oneself & Information

Organize on Timeline & Matrix

Tell the Patient’s Story

O I

Page 57: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Dave’s Chief Complaints

• Weight Gain (30 lbs in last decade) – Mostly over the last 5-7 years, round the waist

• Elevated cholesterol and triglycerides levels • Increased Blood Pressure • Fatigues more easily than in past • Less stamina in exercise and physical

activity • Some muscle and joint stiffness

Page 58: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 59: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 60: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

25 57

Weight Gain/Inc Waist Circ Hypertension Dyslipidemia

Fatigue/Reduce Stamina

50

Electrician; working on construction sites since mid 20s

Weight Gain & Fatigue

Hypertension Incr Chol & LDL

Avid exerciser and runner Reduced exercise

Loves to cook “foodie”

Increased Triglycerides

Incr glucose

Carol’s plan

52 54

Page 61: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 62: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

NO

NO

Possible High Muscle Mass

or Athlete

NO

Increased BIA Fat%?

YES

Abnormal High BMI?

YES YES YES

NO

Gut/Detox/HPATGG dysfunctions?

Assessing Body Composition

YES

NO YES

Ideal Skinny Fat or Metabolically

Obese

NO

Increased WHR?

TLC Nx/ Rx

YES

Increased BIA Fat%?

NO

Increased WHR?

Increased BIA Fat%?

Metabolically Obese

(OverVAT)

YES NO

Gynoid Obesity/ overSAT

Gynoid Obesity/ overSAT

Possible High Muscle Mass

or Large Skeletal Frame

Increased BIA Fat%?

Android Obesity (OverVAT)

MetSyn?

YES

YES

Dx: OverFAT Dx:OverVAT or OverSAT Dx: Overweight

Increased WC?

Increased WC or WHR?

Page 63: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

O T T G

Gather Oneself & Information

Organize on Timeline & Matrix

Tell the Patient’s Story

Order of your Priorities

O I

Page 64: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Nutrition Assessments

PFC-MVP Biomarkers

Gather Organize Re-Tell

Order/Prioritize The ABCDs of

Nutrition Evaluation

Page 65: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Where’s the Ink?

Page 66: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Pattern Recognition

Undernourished

Reduce Exposures

Ensure a Safe Detox

Page 67: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Pattern Recognition

Undernourished

Reduce Exposures

Ensure a Safe Detox

Page 68: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

TOTAL TOXIC LOAD equals

Total Toxic Exposure minus

Ability to Detoxify and

Eliminate Toxins

Page 69: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Where’s the Ink?

Page 70: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Obesity, VAT (Incr WHR) Hypertension Endothelial Dysfunction??? Joint stiffness morning

Mild Testosterone Deficiency??? Insulin Resistance??? Insulin Resistance???

Blood Sugar Elevation HTN and Met Syn???

Occupational Exposure

Fatigue Muscle Soreness

Obesity, VAT (Incr WHR) Endothelial Dysfunction??? Joint stiffness morning

Page 71: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Pattern Recognition

Undernourished

Reduce Exposures

Ensure a Safe Detox

Page 72: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Functional Nutrition

Page 73: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Macronutrients

Page 74: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Micronutrients & Phytonutrients

Page 75: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 76: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Pattern Recognition

Undernourished

Reduce Exposures

Ensure a Safe Detox

Page 77: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Minimizing Toxic Exposure • Avoid cigarette smoke & charred meat • Test home for radon • Eat organic foods; buy organic flowers • Drink purified or spring water • Eat generous amounts of sea vegetables,

green algae, &/or Spirulina • Minimize consumption of certain fish & shellfish

– Mercury in large tuna, swordfish, shark, king mackerel, tilefish – PCBs in farmed salmon & sport fish (Great Lakes; Hudson R) – Oysters “downstream” from wastewater

• Drink alcohol in moderation • Don’t take acetaminophen for a hangover • Avoid polypharmacy

Page 78: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

• Avoid synthetic pesticides/ herbicides • Use non toxic cleaning agents; patronize chemical

free dry-cleaners • Use nontoxic building materials & carpets • Use “natural” cosmetics, shampoos, nail polish &

fragrances • Clean indoor air with plants and ionizers • Use polyethylene (“clear”) food wrap (if any) • Don’t microwave plastics! • Use BPA-free water bottles & canned food • Don’t overheat empty Teflon® cookware • Don’t lick picnic tables or wooden rails!

Minimizing Toxic Exposure

Page 79: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Remove Toxic Foods

Food toxins include:

– Petrochemical residues from some farming practices

– Mercury from industrial waste in fish

– Lead in the water – Advanced glycation

endproducts (AGEs) from food preparation (overcooking)

– Polyaromatic hydrocarbons from charbroiled meat

– Trans fats – Naturally-occurring plant toxins

(e.g., aflatoxin)

Page 80: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Include Clean, Nourishing Foods Eat foods which:

– Nourish the organs of detoxification (e.g., liver)

– Provide substrates and cofactors for optimal detoxification through cellular, hepatic, gastrointestinal, and renal mechanisms

– Modify genetic expression

– Provide phytochemicals that impact cellular signaling

Page 81: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 82: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Pattern Recognition

Undernourished

Reduce Exposures

Ensure a Safe Detox

Page 83: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 84: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

O T T G

Gather Oneself & Information

Organize on Timeline & Matrix

Tell the Patient’s Story

Order of your Priorities

Initiate Assessment and Care

O I

Page 85: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Nutrition Assessments

PFC-MVP Biomarkers

Gather Organize Re-Tell

Order/Prioritize The ABCDs of

Nutrition Evaluation

Nutrition Therapeutic Interventions

Page 86: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Nutrition Assessments

PFC-MVP Biomarkers

Gather Organize Re-Tell

Order/Prioritize The ABCDs of

Nutrition Evaluation

Nutrition Therapeutic Interventions

Page 87: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Page 88: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

Why is Food Important to

Your Patient’s

Detoxification Process?

Page 89: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

Food Plays a Role in All Phases of Detoxification

Toxins In

Phase I Support

Phase I Protection

Phase II Support

Toxins Out

FOOD

Page 90: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

O T T G

Gather Oneself & Information

Organize on Timeline & Matrix

Tell the Patient’s Story

Order of your Priorities

Initiate Assessment and Care

Track Progress

O I

Page 91: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

CHANGING THE WAY WE DO MEDICINE, AND THE MEDICINE WE DO

www.functionalmedicine.org

Page 92: A Case Study Discussion of the New Era of Applying the ...congress.metagenics.com.au/.../3-kristi-hughes-functional-medicine.pdf · of Applying the Functional Medicine Model to Patient

©2014 The Institute for Functional Medicine

Attributions and Recognized Contributors to IFM Content Development

• IFM Medical Education Team

– Patrick Hanaway, MD, Dan Lukaczer ND • Functional Nutrition Development Team

– Elizabeth Boham, MD, Ruth Debusk PhD, RD, MS, Deanna Minich, PhD, Michael Stone, MS, MD, Barb Schiltz, MS, Mary Willis RD

• Staff at Institute for Functional Medicine • Faculty Contributors

– John Cline, MD, Kara Fitzgerald, N.D., David Jones, MD, Rick Mayfield, DC, CCN, Robert Rountree MD, Shilpa Saxena, MD

• Previous Contributors – Diana Noland, RD,MPH,CCN, Kathy Mahan, RD,

Linda Massey, RD, PhD, Alex Vasquez, DO, ND,DC